Document:

Ninth Supplemental Indenture

 Exhibit 4.1 

 
  

NINTH SUPPLEMENTAL INDENTURE 
 Dated as of April 23, 2012 
  

 
 between

 LOWE’S COMPANIES, INC. 
 and 
 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. 

as Trustee 
  

 
 Supplemental to
the Amended and Restated Indenture 
 Dated as of December 1, 1995 

 
  

Creating a Series of Securities designated 
 1.625% Notes due 2017, 
 Creating a Series of Securities designated 

3.120% Notes due 2022, 
 and 
 Creating a Series of Securities designated 

4.650% Notes due 2042 

 NINTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2012 (this “Ninth
Supplemental Indenture”), between LOWE’S COMPANIES, INC., a corporation duly organized and existing under the laws of the State of North Carolina (the
“Company”), having its principal office at 1000 Lowe’s Boulevard, Mooresville, North Carolina 28117, and THE BANK OF NEW YORK MELLON
TRUST COMPANY, N.A., a national banking association duly organized and existing under the laws of the United States, as Trustee (the “Trustee” or the “Successor Trustee”) as successor
trustee to J.P. Morgan Trust Company, National Association (the “Resigning Trustee”), pursuant to that certain Instrument of Resignation, Appointment and Acceptance, dated as of April 21, 2004 (the “Resignation
Instrument”). 
 W I T N E S S E T H: 
 WHEREAS, the Company has heretofore executed and delivered to the Resigning Trustee an Amended and Restated Indenture, dated as of December 1, 1995 (the “Base Indenture”) as
supplemented and amended by this Ninth Supplemental Indenture (together with the Base Indenture, the “Indenture”), providing for the issuance from time to time of its unsecured unsubordinated debentures, notes or other evidences of
indebtedness (the “Securities”), to be issued in one or more series as provided in the Base Indenture; 

WHEREAS, pursuant to the Resignation Instrument and the applicable provisions of the Base Indenture, the Resigning Trustee assigned,
transferred, delivered and confirmed to the Successor Trustee all right, title and interest of the Resigning Trustee under the Indenture, with like effect as if the Successor Trustee was originally named as trustee under the Indenture, and the
Company accepted the resignation of the Resigning Trustee as trustee, Paying Agent, Security Registrar, Conversion Agent and Agent under the Indenture and duly appointed the Successor Trustee as trustee, Paying Agent, Security Registrar, Conversion
Agent and Agent under the Indenture and confirmed to the Successor Trustee all the rights, powers and trusts of the Resigning Trustee under the Base Indenture; 
 WHEREAS, it is provided in Section 901 of the Base Indenture that, without the consent of any Holders, the Company, when authorized by a Board Resolution, and the Trustee may enter into indentures
supplemental thereto (1) to add to, change or eliminate any of the provisions of the Indenture in respect of one or more series of Securities, provided that any such addition, change or elimination (i) shall neither (A) apply
to any Security of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (B) modify the rights of the Holder of any such Security with respect to such provision or
(ii) shall become effective only when there is no such Security Outstanding, (2) to add to the covenants of the Company for the benefit of the Holders of all or any series of Securities (and if such covenants are to be for the benefit of
less than all series of Securities, stating that such covenants are expressly being included solely for the benefit of such series) and (3) to establish the form or terms of Securities of any series as permitted by Sections 201 and 301 of the
Base Indenture; 
 WHEREAS, the Company, in the exercise of the power and authority conferred upon and reserved to it under the
provisions of the Indenture and pursuant to appropriate Board Resolutions and actions of its authorized officers, has duly determined to make, execute and deliver to the Trustee this Ninth Supplemental Indenture in order to establish the form and
terms 

 
of, and to provide for the creation and issuance of, three new series of Securities designated as its (i) 1.625% Notes due 2017 (the “2017 Notes”) in an aggregate Principal
Amount at Maturity of $500,000,000, (ii) 3.120% Notes due 2022 (the “2022 Notes”) in an aggregate Principal Amount at Maturity of $750,000,000 and (iii) 4.650% Notes due 2042 (the “2042 Notes” and,
together with the 2017 Notes and the 2022 Notes, the “Notes”) in an aggregate Principal Amount at Maturity of $750,000,000; and 
 WHEREAS, all acts and requirements necessary to make the Notes, when executed by the Company and authenticated and delivered by the Trustee or any Authenticating Agent (as defined in the Indenture) and
issued upon the terms and subject to the conditions of the Indenture against payment therefor, the valid, binding and legal obligations of the Company and to make this Ninth Supplemental Indenture a valid and legally binding supplement to the
Indenture have been done. 
 NOW, THEREFORE, in order to establish the form and terms of the series of the 2017 Notes, the
series of the 2022 Notes and the series of the 2042 Notes and for and in consideration of the premises and of the covenants contained in the Indenture and for other good and valuable consideration the receipt and sufficiency of which are hereby
acknowledged, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders, as follows: 

ARTICLE I 

DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 
 Section 101. Definitions. For all purposes of the Base Indenture and this Ninth Supplemental Indenture relating to the respective series of Notes created hereby, except as otherwise expressly
provided or unless the context otherwise requires, the terms used in this Ninth Supplemental Indenture have the meanings assigned to them in this Article. Each capitalized term that is used in this Ninth Supplemental Indenture but not defined herein
shall have the meaning specified in the Base Indenture. 
 “Business Day” means any day other than a Saturday
or Sunday or a day on which banking institutions or trust companies in New York City are authorized or required by law, regulation or executive order to close. 
 “Change of Control” means the occurrence of any of the following: (a) the consummation of any transaction (including, without limitation, any merger or consolidation) resulting in
any “person” (as that term is used in Section 13(d)(3) of the Securities Exchange Act of 1934)(other than the Company or one of its subsidiaries) becoming the beneficial owner (as defined in Rules 13d-3 and 13d-5 under the Securities
Exchange Act of 1934), directly or indirectly, of more than 50% of the Voting Stock of the Company or other Voting Stock into which Voting Stock of the Company is reclassified, consolidated, exchanged or changed, measured by voting power rather than
number of shares; (b) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in a transaction or a series of related transactions, of all or substantially all of the assets of the
Company and the assets of its subsidiaries, taken as a whole, to one or more “persons” (as that term is defined in 

  
 2 

 
the Indenture)(other than the Company or one of its subsidiaries); or (c) the first day on which a majority of the members of the Board of Directors of the Company are not Continuing
Directors. Notwithstanding the foregoing, a transaction shall not be considered a Change of Control if (a) the Company becomes a direct or indirect wholly-owned subsidiary of a holding company and (b)(y) immediately following that transaction,
the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of Voting Stock of the Company immediately prior to that transaction or (z) immediately following that transaction no person is
the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of the holding company. 
 “Change of
Control Triggering Event” means the occurrence of both a Change of Control and a Rating Event. 
 “Comparable
Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to the remaining term of the Notes of that series to be redeemed that would be utilized, at the time of selection and
in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes of that series. 
 “Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations for such redemption date, after excluding the
highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Trustee obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer
Quotation is received, such quotation. 
 “Continuing Directors” means, as of any date of determination, any
member of the Company’s Board of Directors who (a) was a member of the Company’s Board of Directors on the date the Notes were issued or (b) was nominated for election, elected or appointed to the Board of Directors by or with
the approval (given either before or after such member’s election or appointment) of a majority of the Continuing Directors who were members of the Board of Directors at the time of such nomination, election or appointment. 

“Depositary” means, with respect to the Notes issuable in whole or in part in global form, DTC and any nominee thereof,
until a successor is appointed and becomes such pursuant to the applicable provisions of the Indenture, and thereafter “Depositary” shall mean or include such successor and any nominee thereof. 

“DTC” means The Depository Trust Company. 
 “Global Note” means a Note issued in global form and deposited with or on behalf of the Depositary, substantially in the form of the Note attached hereto as Exhibit A-1, Exhibit A-2 or
Exhibit A-3. 
 “Interest Payment Date” has the meaning set forth in Section 204(a) of this Ninth
Supplemental Indenture. 
 “Investment Grade Rating” means a rating equal to or higher than Baa3 (or the
equivalent) by Moody’s and BBB- (or the equivalent) by S&P, and the equivalent investment 

  
 3 

 
grade credit rating from any replacement rating agency or Rating Agencies selected by the Company. 
 “Moody’s” means Moody’s Investors Service, Inc. 

“Principal Amount at Maturity” of the Notes means the principal amount at maturity as set forth on the face of each
respective Note. 
 “Quotation Agent” means the Reference Treasury Dealer appointed by the Company. 

“Rating Agencies” means (a) each of Moody’s and S&P; and (b) if either of Moody’s or S&P
ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the control of the Company, a “nationally recognized statistical rating organization” (within the meaning of Rule 15c3-1(c)(2)(vi)(F)
under the Securities Exchange Act of 1934) selected by the Company as a replacement rating agency for a former rating agency. 

“Rating Event” means the rating on the Notes is lowered by each of the Rating Agencies and the Notes are rated below an
Investment Grade Rating by each of the Rating Agencies on any day within the 60-day period (which 60-day period shall be extended so long as the rating of the Notes is under publicly announced consideration for a possible downgrade by any of the
Rating Agencies) after the earlier of (a) the occurrence of a Change of Control and (b) public notice of the particular Change of Control or the Company’s intention to effect a Change of Control; provided that a Rating Event will not
be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Rating Event for purposes of the definition of Change of Control Triggering Event) if each Rating Agency making the reduction in rating does not
publicly announce or confirm or inform the Trustee in writing at the request of the Company that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the Change of
Control (whether or not the applicable Change of Control has occurred at the time of the Rating Event). 
 “Reference
Treasury Dealer” means (i) a Primary Treasury Dealer (as defined herein) selected by Wells Fargo Securities, LLC, (ii) Goldman, Sachs & Co. and (iii) a Primary Treasury Dealer selected by U.S. Bancorp Investments,
Inc. (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a
“Primary Treasury Dealer”), the Company will substitute therefor another Primary Treasury Dealer, and (iv) any other Primary Treasury Dealer selected by the Company. 

“Reference Treasury Dealer Quotations” means, with respect to such Reference Treasury Dealer and any redemption date,
the average of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Trustee by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the
third Business Day preceding such redemption date. 
 “Regular Record Date” has the meaning set forth in
Section 204(a) of this Ninth Supplemental Indenture. 

  
 4 

 “S&P” means Standard & Poor’s Rating Services, a division
of The McGraw-Hill Companies, Inc. 
 “Stated Maturity” has the meaning set forth in Section 203 of this
Ninth Supplemental Indenture. 
 “Treasury Rate” means, with respect to any redemption date, the rate per annum
equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price of such redemption
date. 
 “Underwriting Agreement” means the Underwriting Agreement, dated April 16, 2012, among the
Company and Wells Fargo Securities, LLC, Goldman, Sachs & Co. and U.S. Bancorp Investments, Inc. 
 “Voting
Stock” means, with respect to any specified person (as that term is used in Section 13(d)(3) of the Securities Exchange Act of 1934) as of any date, the capital stock of such person that is at the time entitled to vote generally in the
election of the board of directors of such person. 
 Section 102. Section References. Each reference to a
particular section set forth in this Ninth Supplemental Indenture shall, unless the context otherwise requires, refer to this Ninth Supplemental Indenture. Each reference to a particular section of the Base Indenture shall refer to that particular
section of the Base Indenture. 
 ARTICLE II 
 THE NOTES 
 Section 201. Title of the Notes. The Company hereby
creates the 2017 Notes, the 2022 Notes and the 2042 Notes, each as a separate series of its Securities issued pursuant to the Indenture. The 2017 Notes shall be designated as the “1.625% Notes due 2017,” the 2022 Notes shall be designated
as the “3.120% Notes due 2022,” and the 2042 Notes shall be designated as the “4.650% Notes due 2042.” 

Section 202. Amount. The aggregate Principal Amount at Maturity of the 2017 Notes that may be authenticated and delivered
under this Ninth Supplemental Indenture is initially limited to $500,000,000, the aggregate Principal Amount at Maturity of the 2022 Notes that may be authenticated and delivered under this Ninth Supplemental Indenture is initially limited to
$750,000,000 and the aggregate Principal Amount at Maturity of the 2042 Notes that may be authenticated and delivered under this Ninth Supplemental Indenture is initially limited to $750,000,000. Either series of Notes may be reopened, without the
consent of the holders of the Notes, for issuance of additional Notes of such series. 
 Section 203. Stated
Maturity. The Stated Maturity of the 2017 Notes shall be April 15, 2017, the Stated Maturity of the 2022 Notes shall be April 15, 2022 and the Stated Maturity of the 2042 Notes shall be April 15, 2042. 

  
 5 

 Section 204. Interest and Payment. (a) The 2017 Notes shall bear interest
at 1.625% per annum, the 2022 Notes shall bear interest at 3.120% per annum and the 2042 Notes shall bear interest at 4.650% per annum beginning on the date of issuance until the Notes, respectively, are redeemed, paid or duly
provided for. Interest shall be paid semi-annually in arrears on each April 15 and October 15 (each, an “Interest Payment Date”), commencing on October 15, 2012, to persons in whose names the Notes are registered at
the close of the Business Day on the April 1 immediately preceding each April 15 or the October 1 immediately preceding each October 15 (each a “Regular Record Date”). 

(b) Payments of interest on the Notes shall include interest accrued to, but excluding, the respective Interest Payment Dates. Interest
payments for the Notes shall be computed on the basis of a 360-day year composed of twelve 30-day months. Payments of principal and interest to owners of book-entry interests shall be made to holders of the Notes on the respective Regular Record
Date in accordance with the procedures of DTC and its participants in effect from time to time. Settlement for the Notes shall be made in immediately available funds. All payments of principal and interest shall be made by the Company in immediately
available funds except as set forth in the applicable Note. 
 Section 205. Optional Redemption. (a) Before the date
that is one month (with respect to the 2017 Notes), three months (with respect to the 2022 Notes) or six months (with respect to the 2042 Notes) prior to the applicable maturity date for such series of Notes, the Notes of each series will be
redeemable, in whole at any time or in part from time to time, at the Company’s option at a redemption price equal to the greater of: 
 (i)         100% of the principal amount of the Notes to be redeemed; or 

(ii)        the sum of the present values of the remaining scheduled payments of
principal and interest thereon (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Treasury Rate, plus 15 basis points with respect to the 2017 Notes, 20 basis points with respect to the 2022 Notes and 25 basis points with respect to the 2042 Notes; 
 plus, in each case, accrued and unpaid interest thereon to, but excluding, the date of redemption. 
 (b) On or after the date that is one month (with respect to the 2017 Notes), three months (with respect to the 2022 Notes) or six months (with respect to the 2042 Notes) prior to the applicable maturity
date for such series of Notes, the Notes of each series will be redeemable, in whole at any time or in part from time to time, at the Company’s option at par plus accrued and unpaid interest thereon to, but excluding, the date of redemption.

 (c) Notwithstanding the foregoing, installments of interest on Notes that are due and payable on Interest Payment Dates
falling on or prior to a redemption date will be payable on the Interest Payment Date to the registered holders as of the close of the Business Day on the relevant record date. 

(d) Notice of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date set forth in such
notice to each registered holder of the 2017 Notes, 

  
 6 

 
the 2022 Notes and/or the 2042 Notes, as the case may be, to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the applicable Redemption Date, interest
will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the Notes to be redeemed shall be selected by the Trustee by a method the Trustee deems to be fair and appropriate.

 Section 206. Change of Control Offer to Purchase. 

(a) If a Change of Control Triggering Event occurs, holders of Notes may require the Company to repurchase all or any part (equal to
$2,000 or an integral multiple of $1,000 in excess thereof) of their Notes at a purchase price of 101% of the principal amount, plus accrued and unpaid interest, if any, on such Notes to the date of purchase (unless a notice of redemption has been
mailed within 30 days after such Change of Control Triggering Event stating that all of the Notes will be redeemed as described in this Section 206). The Company shall be required to mail to holders of the Notes a notice describing the
transaction or transactions constituting the Change of Control Triggering Event and offering to repurchase the Notes. The notice must be mailed within 30 days after any Change of Control Triggering Event, and the repurchase must occur no earlier
than 30 days and no later than 60 days after the date the notice is mailed. 
 (b) On the date specified for repurchase of the
Notes, the Company shall, to the extent lawful: 

(i)         accept for payment all properly tendered Notes or portions of
Notes; 
 (ii)        deposit with the paying agent the required payment
for all properly tendered Notes or portions of Notes; and 

(iii)       deliver to the Trustee the repurchased Notes, accompanied by an
Officers’ Certificate stating, among other things, the aggregate principal amount of repurchased Notes. 
 (c) The Company
shall comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934 and any other securities laws and regulations applicable to the repurchase of the Notes. To the extent that these requirements conflict with the provisions
requiring repurchase of the Notes, the Company shall comply with such requirements instead of the repurchase provisions and shall not be considered to have breached its obligations with respect to repurchasing the Notes. Additionally, if an Event of
Default exists under the Indenture (which is unrelated to the repurchase provisions of the Notes), including the events of default arising with respect to other issues of debt securities, the Company shall not be required to repurchase the Notes
notwithstanding these repurchase provisions. 
 (d) The Company shall not be required to comply with the obligations of this
Section 206 if a third party instead satisfies them. 
 Section 207. Forms; Denominations. The Notes shall be
Registered Securities and shall be issued in minimum denominations of $2,000 and integral multiples of $1,000 thereafter. The certificates for the Notes shall be in substantially the forms attached hereto as Exhibit A-1, Exhibit A-2 and Exhibit A-3.

  
 7 

 (a) Global Notes. (i) Notes shall be issued initially in the form of one or more
Global Notes in definitive fully registered form without interest coupons, deposited on behalf of the subscribers for the Notes represented thereby with The Bank of New York Mellon Trust Company, N.A., at its Corporate Trust Office, as custodian for
the Depositary and registered in the name of DTC or a nominee thereof, duly executed by the Company and authenticated by the Trustee as provided in the Indenture. The aggregate Principal Amount at Maturity of the Global Notes may from time to time
be increased or decreased by adjustments made on the records of the Trustee and the Depositary as hereinafter provided. 
 (ii) Book-Entry Provisions. The Company shall execute and the Trustee shall, in accordance with this Section 207(a)(ii) and Section 303 of the Base Indenture, authenticate and deliver initially
one or more Global Notes that (x) shall be registered in the name of the Depositary, (y) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instructions and (z) shall bear legends substantially to
the following effect: 
 “UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO LOWE’S COMPANIES, INC. OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR TO SUCH OTHER ENTITY OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.” 

Section 208. Applicability of Reports by the Company. For purposes of this Ninth Supplemental Indenture, to the extent
information, documents or reports are required to be filed with the Commission and delivered to the Trustee or the Holders, the availability of such information, documents or reports on the Commission’s Electronic Data Gathering Analysis and
Retrieval (“EDGAR”) system or its Interactive Data Electronic Applications (“IDEA”) system or the Company’s website shall be deemed to have satisfied such delivery requirements to the Trustee and the Holders.

 Section 209. Applicability of Sinking Funds. The provisions of Article Twelve of the Base Indenture shall not
apply to the 2017 Notes, the 2022 Notes or the 2042 Notes. 

  
 8 

 Section 210. Applicability of Repayment of Securities at Option of Holders. The
provisions of Article Thirteen of the Base Indenture shall not apply to the 2017 Notes, the 2022 Notes or the 2042 Notes. 

Section 211. Applicability of Conversion of Securities. The provisions of Article Fourteen of the Base Indenture shall not
apply to the 2017 Notes, the 2022 Notes or the 2042 Notes. 
 ARTICLE III 

MISCELLANEOUS PROVISIONS 
 Section 301. Concerning the Indenture. Except as expressly amended hereby, the Base Indenture shall continue in full force and effect in accordance with the provisions thereof and the Base
Indenture is in all respects hereby ratified and confirmed. This Ninth Supplemental Indenture and all its provisions shall be deemed a part of the Base Indenture in the manner and to the extent herein and therein provided. 

Section 302. Severability. If any provision in this Ninth Supplemental Indenture shall be invalid, illegal or unenforceable,
the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

Section 303. Trust Indenture Act. If any provision in this Ninth Supplemental Indenture limits, qualifies or conflicts with
any other provision hereof or of the Base Indenture which provision is required to be included in the Base Indenture by any of the provisions of the Trust Indenture Act, such required provision shall control. 

Section 304. Trustee. The recitals and statements herein are deemed to be those of the Company and not of the Trustee. The
Trustee makes no representations as to the validity or sufficiency of this Ninth Supplemental Indenture. 
 Section 305.
Governing Law. This Ninth Supplemental Indenture shall be governed by, and construed in accordance with, the laws of the State of New York. 
 Section 306. Multiple Originals. This Ninth Supplemental Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such
counterparts shall together constitute but one and the same instrument. 

  
 9 

 IN WITNESS WHEREOF, the parties have caused this Ninth Supplemental Indenture to be duly
executed. 
  

					
	LOWE’S COMPANIES, INC.
		
	By:	 	 /s/ Robert F. Hull, Jr.

		 	Name:	 	Robert F. Hull, Jr.
		 	Title:	 	Executive Vice President and Chief Financial Officer
	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	 /s/ Scott Williams

		 	Name:	 	Scott Williams
		 	Title:	 	Senior Associate

 Signature Page to Ninth Supplemental Indenture 

 EXHIBIT A-1 
 FORM OF GLOBAL NOTE 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO LOWE’S COMPANIES, INC. OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR TO SUCH OTHER ENTITY OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

LOWE’S COMPANIES, INC. 
 1.625% Notes due April 15, 2017 
 GLOBAL SECURITY 

 

			
	No.	  	CUSIP No.
		  	  
 $

		  	  
 Original Principal Amount

 Lowe’s Companies, Inc., a corporation duly organized and existing under the laws of the State of
North Carolina (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co. or its registered assigns, the principal
sum of $         on April 15, 2017, at the office or agency of the Company referred to below, in such coin or currency of the United States of America as at the time of payment is legal tender for the
payment of public and private debts, and to pay interest thereon in like coin or currency from April 23, 2012, or from the most recent Interest Payment Date on which interest has been paid or duly provided for, semi-annually in arrears on
April 15 and October 15 in each year, commencing October 15, 2012, at the rate of 1.625% per annum until the principal hereof is paid or made available for payment, and (to the extent lawful) to pay interest at the same rate per
annum on any overdue principal and premium and on any overdue installments of interest until paid. 
 The interest so payable,
and punctually paid or duly provided for, on any Interest Payment Date, as provided in the Amended and Restated Indenture, dated as of December 1, 1995 (the “Base Indenture”) between the Company and The Bank of New York Mellon Trust
Company, N.A., as trustee (the “Trustee”), as supplemented by the Ninth Supplemental Indenture dated as of April 23, 2012, between the Company and the Trustee (the “Ninth 

  
 A-1-1

 
Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) shall be paid to the Person in whose name this Note is registered at the close of business on the
respective Regular Record Date for such interest, which shall be the April 1 or October 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly
provided for will forthwith cease to be payable to the Person in whose name this Note is registered on such Regular Record Date and may either be paid to the Person in whose name this Note is registered at the close of business on a Special Record
Date for the payment of such Defaulted Interest to be fixed in accordance with Section 307 of the Base Indenture by the Trustee, notice whereof shall be given to the Person in whose name this Note is registered not less than ten days prior to
such Special Record Date, or be paid at any time in any other lawful manner, all as more fully provided in the Indenture. 

This Note is a “book-entry” note and is being registered in the name of Cede & Co. as nominee of The Depository Trust
Company (“DTC”), a clearing agency. Subject to the terms of the Indenture, this Note will be held by a clearing agency or its nominee, and beneficial interests will be held by beneficial owners through the book-entry facilities of such
clearing agency or its nominee in minimum denominations of $2,000 and increments of $1,000 in excess thereof. 
 As long as this
Note is registered in the name of DTC or its nominee, the Trustee will make payments of principal of and interest on this Note by wire transfer of immediately available funds to DTC or its nominee. Notwithstanding the above, the final payment on
this Note will be made after due notice by the Trustee of the pendency of such payment and only upon presentation and surrender of this Note at its principal corporate trust office or such other office or agencies appointed by the Trustee for that
purpose and such other locations provided in the Indenture. 
 Payments of principal of (and premium, if any) and interest on
this Note will be made at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for
payments of public and private debts; provided, however, that at the option of the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security
Register. 
 This Note is one of a duly authorized series of notes of the Company, designated 1.625% Notes due 2017 (the
“Notes”), initially limited in aggregate principal amount at any time outstanding to FIVE HUNDRED MILLION DOLLARS ($500,000,000) which may be issued under the Indenture. This series of Notes may be reopened, without the consent of the
holders of the Notes, for issuance of additional Notes. Reference is hereby made to the Indenture and all indentures supplemental thereto which are applicable to the Notes for a statement of the respective rights, limitations of rights, duties,
obligations and immunities thereunder of the Company, the Trustee and the Holders of the Notes, and the terms upon which the Notes are, and are to be, authenticated and delivered. All terms used in this Note that are defined in the Indenture shall
have the meanings assigned to them in the Indenture. 
 The Notes do not have the benefit of any sinking fund obligations.

  
 A-1-2

 Before the date that is one month prior to April 15, 2017, the Notes will be
redeemable, in whole at any time or in part from time to time, at the Company’s option at a redemption price equal to the greater of: 
 (i)         100% of the principal amount of the Notes to be redeemed; or 
 (ii)        the sum of the present values of the remaining scheduled payments of principal and interest thereon (not including any portion of such payments of
interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 15 basis points; 

plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 

On or after the date that is one month prior to April 15, 2017, the Notes will be redeemable, in whole at any time or in part from
time to time, at the Company’s option at par plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 
 Notwithstanding the previous two paragraphs, installments of interest on Notes that are due and payable on Interest Payment Dates falling on or prior to a redemption date will be payable on the Interest
Payment Date to the registered holders as of the close of the Business Day on the relevant record date. 
 Notice of any
redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each registered holder of the Notes to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the Redemption Date,
interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the Notes to be redeemed shall be selected by the Trustee by a method the Trustee deems to be fair and
appropriate. 
 Upon a Change of Control Triggering Event, the Company shall be required to make an offer to repurchase the
Notes on the terms set forth in the Indenture. 
 If an Event of Default shall occur and be continuing, the principal of all the
Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
 The Indenture contains
provisions for defeasance at any time of (a) the entire indebtedness of the Company under this Note and (b) certain restrictive covenants and the related defaults and Events of Default applicable to the Company, in each case, upon
compliance by the Company with certain conditions set forth in the Indenture, which provisions apply to this Note. 
 The
Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes under the Indenture at any time by the Company and the
Trustee with the consent of the Holders of a majority in aggregate principal amount of the Notes at the time Outstanding. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the
Notes at the time Outstanding, on behalf of the Holders of all Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past Defaults under the Indenture and their consequences. Any such

  
 A-1-3

 
consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer
thereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 

No reference herein to the Indenture and provisions of this Note or of the Indenture shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Note at the times, place and rate, and in the coin or currency, as herein prescribed. 

As provided in the Indenture and subject to certain limitations on transfer of this Note by DTC or its nominee, the transfer of this Note
is registrable in the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in the Borough of Manhattan, The City of New York, duly endorsed by, or accompanied by a written instrument of
transfer in the form attached hereto duly executed by the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount, shall be issued to the
designated transferee or transferees. 
 The Notes are issuable only in registered form in minimum denominations of $2,000 and
integral multiples of $1,000 thereafter. As provided in the Indenture and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes of different authorized denomination, as requested
by the Holder surrendering the same. 
 No service charge shall be made for any such registration of transfer or exchange of
Notes, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Prior to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company, or the Trustee may treat the Person in whose name this Note is registered as the
owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Trustee or any such agent shall be affected by notice to the contrary. 
 Interest on this Note shall be computed on the basis of a 360-day year of twelve 30-day months. 
 The Company shall furnish to any Holder of record of Notes, upon written request and without charge, a copy of the Indenture. 
 The Indenture and this Note each shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of law. 

Unless the certificate of authentication hereon has been executed by the Trustee by manual signature, this Note shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 A-1-4

 IN WITNESS WHEREOF,
LOWE’S COMPANIES, INC. has caused this Note to be signed by a duly elected or appointed, qualified and serving officer and attested by a duly elected or appointed, qualified and
serving officer. 
  

			
	LOWE’S COMPANIES, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	 Dated: April 23, 2012

		
	Attest:	 	  

		 	Name:
		 	Title:

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

THIS IS ONE OF THE SECURITIES OF
THE SERIES DESIGNATED THEREIN REFERRED TO IN THE WITHIN-MENTIONED INDENTURE.

  

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY,
N.A.
	 as Trustee

		
	By:	 	  

		 	Authorized Officer

  
 A-1-5

 ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this Note, shall be construed as though they were written out in full according to applicable laws or regulations: 

TEN COM - tenants in common 
 TEN ENT - tenants by the entireties 
 JT TEN - joint tenants with right of
survivorship and not as tenants in common 
 CUST - Custodian 

U/G/M/A or UNIF GIFT MIN ACT - Uniform Gifts to Minors Act 
 Additional abbreviations may also be used though not in the above list. 

  
 A-1-6

 FORM OF TRANSFER 

 

			
	 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

	
	  

	
	  

	(Please print or typewrite name and address of assignee)
	
	  

	(Please insert Social Security or other identifying Number of Assignee)
	
	
	the within Note of Lowe’s Companies, Inc. and does hereby irrevocably constitute and appoint
		
	                             
                                         
                                         
                                         
                                        
,	 	Attorney, to
	transfer the said Note on the books of the within named Lowe’s Companies, Inc., with full power of substitution in the premises.

  

			
	Dated:	 	  

  

			
	  

NOTICE: The signature to this assignment must correspond with the name as written upon the face of this Note in every particular without
alteration or enlargement or any change whatever.

  

			
	  
 SIGNATURE
GUARANTEED: The signature must be guaranteed by a member of the Securities Transfer Agents Medallion Program. Notarized or witnessed signatures are not acceptable.

  
 A-1-7

 PAYMENT INSTRUCTIONS 

The assignee should include the following for purposes of payment: 
 Payment shall be made, by wire transfer or otherwise, in immediately available funds, to
                    , for the account of
                    , account number
                    , or, if mailed by check, to
                    . Applicable reports and statements required to be physically delivered under the terms of the Indenture should be
mailed to                     . This information is provided by
                    , the assignee named above, or
                    , as its agent. 

  
 A-1-8

 EXHIBIT A-2 
 FORM OF GLOBAL NOTE 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO LOWE’S COMPANIES, INC. OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR TO SUCH OTHER ENTITY OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

LOWE’S COMPANIES, INC. 
 3.120% Notes due April 15, 2022 
 GLOBAL SECURITY 

 

			
	No.	  	CUSIP No.
		  	  
 $

 

		  	Original Principal Amount

 Lowe’s Companies, Inc., a corporation duly organized and existing under the laws of the State of
North Carolina (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co. or its registered assigns, the principal
sum of $         on April 15, 2022, at the office or agency of the Company referred to below, in such coin or currency of the United States of America as at the time of payment is legal tender for the
payment of public and private debts, and to pay interest thereon in like coin or currency from April 23, 2012, or from the most recent Interest Payment Date on which interest has been paid or duly provided for, semi-annually in arrears on
April 15 and October 15 in each year, commencing October 15, 2012, at the rate of 3.120% per annum until the principal hereof is paid or made available for payment, and (to the extent lawful) to pay interest at the same rate per
annum on any overdue principal and premium and on any overdue installments of interest until paid. 
 The interest so payable,
and punctually paid or duly provided for, on any Interest Payment Date, as provided in the Amended and Restated Indenture, dated as of December 1, 1995 (the “Base Indenture”) between the Company and The Bank of New York Mellon Trust
Company, N.A., as trustee (the “Trustee”), as supplemented by the Ninth Supplemental 

  
 A-2-1

 
Indenture dated as of April 23, 2012, between the Company and the Trustee (the “Ninth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”)
shall be paid to the Person in whose name this Note is registered at the close of business on the respective Regular Record Date for such interest, which shall be the April 1 or October 1 (whether or not a Business Day), as the case may
be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Person in whose name this Note is registered on such Regular Record Date and may either be paid to
the Person in whose name this Note is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed in accordance with Section 307 of the Base Indenture by the Trustee, notice whereof shall
be given to the Person in whose name this Note is registered not less than ten days prior to such Special Record Date, or be paid at any time in any other lawful manner, all as more fully provided in the Indenture. 

This Note is a “book-entry” note and is being registered in the name of Cede & Co. as nominee of The Depository Trust
Company (“DTC”), a clearing agency. Subject to the terms of the Indenture, this Note will be held by a clearing agency or its nominee, and beneficial interests will be held by beneficial owners through the book-entry facilities of such
clearing agency or its nominee in minimum denominations of $2,000 and increments of $1,000 in excess thereof. 
 As long as this
Note is registered in the name of DTC or its nominee, the Trustee will make payments of principal of and interest on this Note by wire transfer of immediately available funds to DTC or its nominee. Notwithstanding the above, the final payment on
this Note will be made after due notice by the Trustee of the pendency of such payment and only upon presentation and surrender of this Note at its principal corporate trust office or such other office or agencies appointed by the Trustee for that
purpose and such other locations provided in the Indenture. 
 Payments of principal of (and premium, if any) and interest on
this Note will be made at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for
payments of public and private debts; provided, however, that at the option of the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security
Register. 
 This Note is one of a duly authorized series of notes of the Company, designated 3.120% Notes due 2022 (the
“Notes”), initially limited in aggregate principal amount at any time outstanding to SEVEN HUNDRED FIFTY MILLION DOLLARS ($750,000,000) which may be issued under the Indenture. This series of Notes may be reopened, without the consent of
the holders of the Notes, for issuance of additional Notes. Reference is hereby made to the Indenture and all indentures supplemental thereto which are applicable to the Notes for a statement of the respective rights, limitations of rights, duties,
obligations and immunities thereunder of the Company, the Trustee and the Holders of the Notes, and the terms upon which the Notes are, and are to be, authenticated and delivered. All terms used in this Note that are defined in the Indenture shall
have the meanings assigned to them in the Indenture. 
 The Notes do not have the benefit of any sinking fund obligations.

  
 A-2-2

 Before the date that is three months prior to April 15, 2022, the Notes will be
redeemable, in whole at any time or in part from time to time, at the Company’s option at a redemption price equal to the greater of: 
 (i)         100% of the principal amount of the Notes to be redeemed; or 
 (ii)        the sum of the present values of the remaining scheduled payments of principal and interest thereon (not including any portion of such payments of
interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 20 basis points; 

plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 

On or after the date that is three months prior to April 15, 2022, the Notes will be redeemable, in whole at any time or in part
from time to time, at the Company’s option at par plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 
 Notwithstanding the previous two paragraphs, installments of interest on Notes that are due and payable on Interest Payment Dates falling on or prior to a redemption date will be payable on the Interest
Payment Date to the registered holders as of the close of the Business Day on the relevant record date. 
 Notice of any
redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each registered holder of the Notes to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the Redemption Date,
interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the Notes to be redeemed shall be selected by the Trustee by a method the Trustee deems to be fair and
appropriate. 
 Upon a Change of Control Triggering Event, the Company shall be required to make an offer to repurchase the
Notes on the terms set forth in the Indenture. 
 If an Event of Default shall occur and be continuing, the principal of all the
Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
 The Indenture contains
provisions for defeasance at any time of (a) the entire indebtedness of the Company under this Note and (b) certain restrictive covenants and the related defaults and Events of Default applicable to the Company, in each case, upon
compliance by the Company with certain conditions set forth in the Indenture, which provisions apply to this Note. 
 The
Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes under the Indenture at any time by the Company and the
Trustee with the consent of the Holders of a majority in aggregate principal amount of the Notes at the time Outstanding. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the
Notes at the time Outstanding, on behalf of the Holders of all Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past Defaults under the Indenture and their consequences. Any such

  
 A-2-3

 
consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer
thereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 

No reference herein to the Indenture and provisions of this Note or of the Indenture shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Note at the times, place and rate, and in the coin or currency, as herein prescribed. 

As provided in the Indenture and subject to certain limitations on transfer of this Note by DTC or its nominee, the transfer of this Note
is registrable in the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in the Borough of Manhattan, The City of New York, duly endorsed by, or accompanied by a written instrument of
transfer in the form attached hereto duly executed by the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount, shall be issued to the
designated transferee or transferees. 
 The Notes are issuable only in registered form in minimum denominations of $2,000 and
integral multiples of $1,000 thereafter. As provided in the Indenture and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes of different authorized denomination, as requested
by the Holder surrendering the same. 
 No service charge shall be made for any such registration of transfer or exchange of
Notes, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Prior to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company, or the Trustee may treat the Person in whose name this Note is registered as the
owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Trustee or any such agent shall be affected by notice to the contrary. 
 Interest on this Note shall be computed on the basis of a 360-day year of twelve 30-day months. 
 The Company shall furnish to any Holder of record of Notes, upon written request and without charge, a copy of the Indenture. 
 The Indenture and this Note each shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of law. 

Unless the certificate of authentication hereon has been executed by the Trustee by manual signature, this Note shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 A-2-4

 IN WITNESS WHEREOF,
LOWE’S COMPANIES, INC. has caused this Note to be signed by a duly elected or appointed, qualified and serving officer and attested by a duly elected or appointed, qualified and
serving officer. 
  

			
	LOWE’S COMPANIES, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	 Dated: April 23, 2012

		
	Attest:	 	  

		 	Name:
		 	Title:

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

THIS IS ONE OF THE SECURITIES OF
THE SERIES DESIGNATED THEREIN REFERRED TO IN THE WITHIN-MENTIONED INDENTURE.

  

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY,
N.A.
	 as Trustee

		
	By:	 	  

		 	Authorized Officer

  
 A-2-5

 ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this Note, shall be construed as though they were written out in full according to applicable laws or regulations: 

TEN COM - tenants in common 
 TEN ENT - tenants by the entireties 
 JT TEN - joint tenants with right of
survivorship and not as tenants in common 
 CUST - Custodian 

U/G/M/A or UNIF GIFT MIN ACT - Uniform Gifts to Minors Act 
 Additional abbreviations may also be used though not in the above list. 

  
 A-2-6

 FORM OF TRANSFER 

 

			
	 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

	
	  

	
	  

	(Please print or typewrite name and address of assignee)
	
	  

	(Please insert Social Security or other identifying Number of Assignee)
	
	the within Note of Lowe’s Companies, Inc. and does hereby irrevocably constitute and appoint
		
	                             
                                         
                                         
                                         
                                        
,	 	Attorney, to
	transfer the said Note on the books of the within named Lowe’s Companies, Inc., with full power of substitution in the premises.

  

			
	Dated:	 	  

  

			
	  

NOTICE: The signature to this assignment must correspond with the name as written upon the face of this Note in every particular without
alteration or enlargement or any change whatever.

  

			
	  
 SIGNATURE
GUARANTEED: The signature must be guaranteed by a member of the Securities Transfer Agents Medallion Program. Notarized or witnessed signatures are not acceptable.

  
 A-2-7

 PAYMENT INSTRUCTIONS 

The assignee should include the following for purposes of payment: 
 Payment shall be made, by wire transfer or otherwise, in immediately available funds, to
                    , for the account of
                    , account number
                    , or, if mailed by check, to
                    . Applicable reports and statements required to be physically delivered under the terms of the Indenture should be
mailed to                     . This information is provided by
                    , the assignee named above, or
                    , as its agent. 

  
 A-2-8

 EXHIBIT A-3 
 FORM OF GLOBAL NOTE 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO LOWE’S COMPANIES, INC. OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR TO SUCH OTHER ENTITY OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL, INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

LOWE’S COMPANIES, INC. 
 4.650% Notes due April 15, 2042 
 GLOBAL SECURITY 

 

			
	No.	  	CUSIP No.
		  	  
 $

		  	  
 Original Principal Amount

 Lowe’s Companies, Inc., a corporation duly organized and existing under the laws of the State of
North Carolina (herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co. or its registered assigns, the principal
sum of $         on April 15, 2042, at the office or agency of the Company referred to below, in such coin or currency of the United States of America as at the time of payment is legal tender for the
payment of public and private debts, and to pay interest thereon in like coin or currency from April 23, 2012, or from the most recent Interest Payment Date on which interest has been paid or duly provided for, semi-annually in arrears on
April 15 and October 15 in each year, commencing October 15, 2012, at the rate of 4.650% per annum until the principal hereof is paid or made available for payment, and (to the extent lawful) to pay interest at the same rate per
annum on any overdue principal and premium and on any overdue installments of interest until paid. 
 The interest so payable,
and punctually paid or duly provided for, on any Interest Payment Date, as provided in the Amended and Restated Indenture, dated as of December 1, 1995 (the “Base Indenture”) between the Company and The Bank of New York Mellon Trust
Company, N.A., as trustee (the “Trustee”), as supplemented by the Ninth Supplemental 

  
 A-3-1

 
Indenture dated as of April 23, 2012, between the Company and the Trustee (the “Ninth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”)
shall be paid to the Person in whose name this Note is registered at the close of business on the respective Regular Record Date for such interest, which shall be the April 1 or October 1 (whether or not a Business Day), as the case may
be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Person in whose name this Note is registered on such Regular Record Date and may either be paid to
the Person in whose name this Note is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed in accordance with Section 307 of the Base Indenture by the Trustee, notice whereof shall
be given to the Person in whose name this Note is registered not less than ten days prior to such Special Record Date, or be paid at any time in any other lawful manner, all as more fully provided in the Indenture. 

This Note is a “book-entry” note and is being registered in the name of Cede & Co. as nominee of The Depository Trust
Company (“DTC”), a clearing agency. Subject to the terms of the Indenture, this Note will be held by a clearing agency or its nominee, and beneficial interests will be held by beneficial owners through the book-entry facilities of such
clearing agency or its nominee in minimum denominations of $2,000 and increments of $1,000 in excess thereof. 
 As long as this
Note is registered in the name of DTC or its nominee, the Trustee will make payments of principal of and interest on this Note by wire transfer of immediately available funds to DTC or its nominee. Notwithstanding the above, the final payment on
this Note will be made after due notice by the Trustee of the pendency of such payment and only upon presentation and surrender of this Note at its principal corporate trust office or such other office or agencies appointed by the Trustee for that
purpose and such other locations provided in the Indenture. 
 Payments of principal of (and premium, if any) and interest on
this Note will be made at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for
payments of public and private debts; provided, however, that at the option of the Company, payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security
Register. 
 This Note is one of a duly authorized series of notes of the Company, designated 4.650% Notes due 2042 (the
“Notes”), initially limited in aggregate principal amount at any time outstanding to SEVEN HUNDRED FIFTY MILLION DOLLARS ($750,000,000) which may be issued under the Indenture. This series of Notes may be reopened, without the consent of
the holders of the Notes, for issuance of additional Notes. Reference is hereby made to the Indenture and all indentures supplemental thereto which are applicable to the Notes for a statement of the respective rights, limitations of rights, duties,
obligations and immunities thereunder of the Company, the Trustee and the Holders of the Notes, and the terms upon which the Notes are, and are to be, authenticated and delivered. All terms used in this Note that are defined in the Indenture shall
have the meanings assigned to them in the Indenture. 
 The Notes do not have the benefit of any sinking fund obligations.

  
 A-3-2

 Before the date that is six months prior to April 15, 2042, the Notes will be
redeemable, in whole at any time or in part from time to time, at the Company’s option at a redemption price equal to the greater of: 
 (i)         100% of the principal amount of the Notes to be redeemed; or 
 (ii)        the sum of the present values of the remaining scheduled payments of principal and interest thereon (not including any portion of such payments of
interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate, plus 25 basis points; 

plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 

On or after the date that is six months prior to April 15, 2042, the Notes will be redeemable, in whole at any time or in part from
time to time, at the Company’s option at par plus accrued and unpaid interest thereon to, but excluding, the date of redemption. 
 Notwithstanding the previous two paragraphs, installments of interest on Notes that are due and payable on Interest Payment Dates falling on or prior to a redemption date will be payable on the Interest
Payment Date to the registered holders as of the close of the Business Day on the relevant record date. 
 Notice of any
redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each registered holder of the Notes to be redeemed. Unless the Company defaults in payment of the redemption price, on and after the Redemption Date,
interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the Notes to be redeemed shall be selected by the Trustee by a method the Trustee deems to be fair and
appropriate. 
 Upon a Change of Control Triggering Event, the Company shall be required to make an offer to repurchase the
Notes on the terms set forth in the Indenture. 
 If an Event of Default shall occur and be continuing, the principal of all the
Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
 The Indenture contains
provisions for defeasance at any time of (a) the entire indebtedness of the Company under this Note and (b) certain restrictive covenants and the related defaults and Events of Default applicable to the Company, in each case, upon
compliance by the Company with certain conditions set forth in the Indenture, which provisions apply to this Note. 
 The
Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes under the Indenture at any time by the Company and the
Trustee with the consent of the Holders of a majority in aggregate principal amount of the Notes at the time Outstanding. The Indenture also contains provisions permitting the Holders of specified percentages in aggregate principal amount of the
Notes at the time Outstanding, on behalf of the Holders of all Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past Defaults under the Indenture and their consequences. Any such

  
 A-3-3

 
consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer
thereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 

No reference herein to the Indenture and provisions of this Note or of the Indenture shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Note at the times, place and rate, and in the coin or currency, as herein prescribed. 

As provided in the Indenture and subject to certain limitations on transfer of this Note by DTC or its nominee, the transfer of this Note
is registrable in the Security Register, upon surrender of this Note for registration of transfer at the office or agency of the Company in the Borough of Manhattan, The City of New York, duly endorsed by, or accompanied by a written instrument of
transfer in the form attached hereto duly executed by the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount, shall be issued to the
designated transferee or transferees. 
 The Notes are issuable only in registered form in minimum denominations of $2,000 and
integral multiples of $1,000 thereafter. As provided in the Indenture and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes of different authorized denomination, as requested
by the Holder surrendering the same. 
 No service charge shall be made for any such registration of transfer or exchange of
Notes, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 Prior to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company, or the Trustee may treat the Person in whose name this Note is registered as the
owner hereof for all purposes, whether or not this Note be overdue, and none of the Company, the Trustee or any such agent shall be affected by notice to the contrary. 
 Interest on this Note shall be computed on the basis of a 360-day year of twelve 30-day months. 
 The Company shall furnish to any Holder of record of Notes, upon written request and without charge, a copy of the Indenture. 
 The Indenture and this Note each shall be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of law. 

Unless the certificate of authentication hereon has been executed by the Trustee by manual signature, this Note shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 A-3-4

 IN WITNESS WHEREOF,
LOWE’S COMPANIES, INC. has caused this Note to be signed by a duly elected or appointed, qualified and serving officer and attested by a duly elected or appointed, qualified and
serving officer. 
  

			
	LOWE’S COMPANIES, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	Dated: April 23, 2012
		
	Attest:	 	  

		 	Name:
		 	Title:

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

THIS IS ONE OF THE SECURITIES OF
THE SERIES DESIGNATED THEREIN REFERRED TO IN THE WITHIN-MENTIONED INDENTURE.

  

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY,
N.A.
	 as Trustee

		
	 By:
	 	  

		 	Authorized Officer

  
 A-3-5

 ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this Note, shall be construed as though they were written out in full according to applicable laws or regulations: 

TEN COM - tenants in common 
 TEN ENT - tenants by the entireties 
 JT TEN - joint tenants with right of
survivorship and not as tenants in common 
 CUST - Custodian 

U/G/M/A or UNIF GIFT MIN ACT - Uniform Gifts to Minors Act 
 Additional abbreviations may also be used though not in the above list. 

  
 A-3-6

 FORM OF TRANSFER 

 

			
	 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

	
	  

	
	  

	(Please print or typewrite name and address of assignee)
	
	  

	(Please insert Social Security or other identifying Number of Assignee)
	
	
	the within Note of Lowe’s Companies, Inc. and does hereby irrevocably constitute and appoint
		
	                             
                                         
                                         
                                         
                                        
,	 	Attorney, to
	transfer the said Note on the books of the within named Lowe’s Companies, Inc., with full power of substitution in the premises.

  

			
	Dated:	 	  

  

			
	  

NOTICE: The signature to this assignment must correspond with the name as written upon the face of this Note in every particular without
alteration or enlargement or any change whatever.

  

			
	  
 SIGNATURE
GUARANTEED: The signature must be guaranteed by a member of the Securities Transfer Agents Medallion Program. Notarized or witnessed signatures are not acceptable.

  
 A-3-7

 PAYMENT INSTRUCTIONS 

The assignee should include the following for purposes of payment: 
 Payment shall be made, by wire transfer or otherwise, in immediately available funds, to
                    , for the account of
                    , account number
                    , or, if mailed by check, to
                    . Applicable reports and statements required to be physically delivered under the terms of the Indenture should be
mailed to                     . This information is provided by
                    , the assignee named above, or
                    , as its agent. 

  
 A-3-8Consulting Agreement

 Exhibit 10.1 
 CONSULTING AGREEMENT 
 This CONSULTING AGREEMENT is made this day of April 20, 2012
(the “Effective Date”) by and between Alnylam Pharmaceuticals, Inc., a Delaware corporation (hereinafter known as “COMPANY”), its successors and assigns, with its principal place of business at 300 Third Street, Cambridge, MA
02142 and Dennis A. Ausiello, M.D. (hereinafter known as “CONSULTANT”), having an address at Massachusetts General Hospital, 55 Fruit Street - GRB 740, Boston, MA 02114. 

COMPANY acknowledges that CONSULTANT is a Staff member of Massachusetts General Hospital (“HOSPITAL”) and a member of the
Faculty of Medicine of Harvard University, and is subject to the policies of those institutions as well as those of Partners HealthCare System, Inc. (“Partners”). COMPANY further acknowledges that CONSULTANT is responsible for a variety of
research, education, patient care, other academically related activities and administrative duties. This CONSULTING AGREEMENT defines the services to be performed by CONSULTANT for COMPANY and the terms that govern those services. 

The parties agree as follows: 
 1. This CONSULTING AGREEMENT will be for an initial term of one (1) year beginning on the Effective Date, and will automatically renew for successive one-year terms unless terminated by either party
pursuant to paragraph 11 (the “TERM”). During the TERM, CONSULTANT shall serve as a consultant to COMPANY and provide the SERVICES (as defined on Schedule A), in a manner consistent with his commitments to HOSPITAL and Partners.

 2. CONSULTANT agrees to make himself available to COMPANY for up to one (1) day per quarter during TERM for the purpose
of providing SERVICES. SERVICES shall not involve substantial use of HOSPITAL resources or any direct or indirect financial support from HOSPITAL, including funding from any outside source awarded to or administered by HOSPITAL. 

3. In consideration for the SERVICES to be performed hereunder, set forth in Schedule A, COMPANY agrees to reimburse CONSULTANT for all
reasonable travel and other expenses, including meals and lodging as may be required, incurred upon its behalf and when authorized by COMPANY. Such expenses shall be confirmed by appropriate receipts and shall be submitted in accordance with COMPANY
standard expense account procedure. 
 4. Subject to the provisions of Paragraphs 5, 6 and 7: 

(A) Any reports, specifications or other materials prepared by CONSULTANT specifically during and in the performance of SERVICES shall be
the property of COMPANY exclusively and shall, to the extent requested in writing by COMPANY, be maintained in confidence by CONSULTANT; 
 (B) CONSULTANT agrees to assign to COMPANY all of CONSULTANT’s rights, title and interest in any invention that is made by CONSULTANT solely or jointly with others during and in the sole performance
of the SERVICES (“INVENTION”). CONSULTANT shall reasonably cooperate with COMPANY, at COMPANY’s expense, to take such steps as customarily needed to enable COMPANY to protect any INVENTION. 

5. Nothing in this Consulting Agreement shall: 
 (A) give the COMPANY any right in or to, any inventions or related ideas and discoveries that (i) received direct or indirect financial support from any Partners institution, or (ii) made use of
any space facilities, materials or other resources of HOSPITAL, or (iii) were otherwise made subject to any grant, contract or other arrangement between an Institution and a third party; 

(B) be construed to restrict or interfere with the CONSULTANT’s obligations under the Hospital’s Intellectual Property
Policy; or 

 (C) be construed to restrict or limit CONSULTANT’S ability to publish the results of
research, education, patient care or other activities performed at or through HOSPITAL, or restrict or limit the ability of CONSULTANT to conduct research, (including that sponsored by any third party), education, patient care, administrative
activities, and academically related activities that CONSULTANT is performing or may perform in the course of, or incidental to, CONSULTANT’s position at HOSPITAL. 
 6. Any information, reports, documents, data, memoranda or other materials disclosed to CONSULTANT relating to the activities of COMPANY that is identified in writing at the time of delivery to CONSULTANT
by COMPANY as having a trade secret or confidential status is solely the property of COMPANY and is to be returned to COMPANY at the termination of this CONSULTING AGREEMENT, provided that CONSULTANT may retain one (1) copy thereof for the sole
purpose of complying with CONSULTANT’s legal obligations under this CONSULTING AGREEMENT. CONSULTANT shall not during the TERM or for a period of three (3) years from the date of disclosure of such COMPANY confidential information to
CONSULTANT, whichever is longer, disclose such confidential information to others or use such confidential information for commercial benefit of CONSULTANT or others, except however, that nothing in this CONSULTING AGREEMENT shall in any way
restrict the right of CONSULTANT to use, disclose, or otherwise deal with any information that, 
 (A) was in the public domain
before the SERVICES were performed; 
 (B) was known to the CONSULTANT before the SERVICES were performed as shown by written
record; 
 (C) was developed by CONSULTANT or on CONSULTANT’s behalf independently of the information disclosed to
CONSULTANT by the Company as shown by written record; 
 (D) is acquired by CONSULTANT from any person entitled to make
disclosure to CONSULTANT unless such person is under an obligation of confidentiality to COMPANY which is known to CONSULTANT; 

(E) becomes public knowledge without breach by CONSULTANT of any obligations of confidence to COMPANY; or 

(F) CONSULTANT is obligated to produce pursuant to an order of a court of competent jurisdiction or a valid administration or
Congressional subpoena, provided that CONSULTANT promptly notifies COMPANY and cooperates reasonably with COMPANY’s efforts to contest or limit the scope of such order. 
 In each case, confidential or proprietary information shall mean only such information which, if disclosed in writing, is clearly marked or labeled as being “confidential” or
“proprietary” or, if disclosed orally, is confirmed to CONSULTANT in writing by the COMPANY as being “confidential” or “proprietary” within 10 business days of each such disclosure. 

7. CONSULTANT represents that CONSULTANT is not a party to any existing agreement which would prevent CONSULTANT entering into this
CONSULTING AGREEMENT. 
 8. This CONSULTING AGREEMENT contains the entire understanding of CONSULTANT and COMPANY with respect
to the matters contained herein. 
 9. Both the COMPANY and CONSULTANT acknowledge and agree that: 

(A) All SERVICES hereunder will be rendered by CONSULTANT as an independent contractor and this CONSULTING AGREEMENT does not create an
employer-employee relationship, and CONSULTANT shall have no rights to receive any employee benefits, such as health and accident insurance, sick leave and vacation, as are in effect generally for employees of COMPANY; 

(B) CONSULTANT is entering into this Agreement in his individual capacity and not as an employee or agent of HOSPITAL or Partners; and

  
 2 

 (C) Neither HOSPITAL nor Partners has any liability or obligation whatsoever hereunder.

 10. CONSULTANT will not originate any publicity, news release or other public announcement, written or oral, relating to this
CONSULTING AGREEMENT without COMPANY’s prior written consent provided, however CONSULTANT may disclose his status as a consultant for COMPANY for the purpose of complying with conflict of interest disclosure requirements HOSPITAL and of any
professional organization, governmental, for profit or not-for-profit funding entity, or professional journal. COMPANY may not use the name of the HOSPITAL, nor that of Partners, nor any variation or adaptation thereof in any advertising,
promotional or sales literature, or other publicity without the prior written approval of HOSPITAL and/or Partners, as applicable. 
 11. Either party shall have the right to terminate the CONSULTING AGREEMENT by thirty (30) days prior written notice. In the event of termination by COMPANY, COMPANY shall owe CONSULTANT for
performance of SERVICES prior to termination. 
 12. The COMPANY shall indemnify, defend and hold harmless CONSULTANT and
CONSULTANT’S successors, heirs and assigns and HOSPITAL and its trustees, employees and staff and their respective successors, heirs and assigns (“Indemnitees”) against any liability, damage, loss or expense (including reasonable
attorneys’ fees and expenses of litigation) incurred by or imposed upon the Indemnitees or any one of them in connection with any claims, suits, actions, demands or judgments arising from the good faith performance of the SERVICES by
CONSULTANT. 
 13. This CONSULTING AGREEMENT shall be governed by the laws of the Commonwealth of Massachusetts. 

14. The obligations of the parties under paragraphs 4, 5, and 6 (for a period of three (3) years), 11, 12 and 13 shall survive the
termination or expiration of this CONSULTING AGREEMENT. 
 Agreed to and Accepted: 

 

			
	CONSULTANT
	
	 /s/ Dennis Ausiello

		
	NAME	 	 Dennis Ausiello

			
		
	DATE	 	 April 16, 2012

			
		
	EFFECTIVE DATE	 	 April 20, 2012

 

			
	ALNYLAM PHARMACEUTICALS, INC.
		
	BY	 	 /s/ John Maraganore

			
		
	NAME	 	 John Maraganore

			
		
	DATE	 	 April 16, 2012

 
 

  
 3 

 SCHEDULE A 
 Scope of Services 
 CONSULTANT agrees to serve as a member of COMPANY’s Scientific Advisory
Board (“SAB”). CONSULTANT will make good faith efforts to attend and participate in quarterly meetings of the SAB at Alnylam or such other place as Alnylam may designate. 

  
 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]